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Endocytosis of light chains induces cytokines through activation Recent studies have focused on protein overloading
of NF-B in human proximal tubule cells. of proximal tubular epithelia and the resultant cytokine
Background. In proteinuric states increased cytokine pro- production as an important mechanism of interstitial in-duction through endocytosis of filtered proteins by proximal
flammation responsible for progression of chronic renaltubule cells (PTCs) has been proposed as a major mechanism
insufficiency in proteinuric diseases [1–8]. In experimen-mediating tubulointerstitial injury and progressive kidney dis-
ease. We studied the effects of six different light chains (LCs) tal studies, increased endocytosis of filtered proteins by
on the production of cytokines in cultured human PTCs. proximal tubule cells (PTCs) has been shown to induce
Methods. LCs were isolated and purified from the urine of proinflammatory and inflammatory cytokines by PTCs,patients with myeloma and human PTCs were exposed to either
possibly mediating tubulointerstitial injury [3, 4, 7]. ThisLC or human serum albumin (HSA) for up to 24 hours. LC
mechanism has emerged as an important contributor ofendocytosis was monitored by immunocytochemistry. Cyto-
kines were determined by enzyme-linked immunosorbent assay interstitial inflammation and progression of renal disease
(ELISA) in the supernatants and activation of nuclear factor- in proteinuric states.
kappa B (NF-B) was detected by electrophoretic mobility shift
Multiple myeloma is a B-cell neoplasm characterizedassays (EMSA) and immunocytochemistry.
by bone marrow infiltration with malignant plasma cells,Results. Endocytosis of LCs induced the release of interleu-
kins (IL) IL-6, IL-8 and monocyte chemoattractant protein-1 which synthesize and secrete monoclonal immunoglobu-
(MCP-1); however, there was considerable variability among lin fragments [9]. It is the sixth most common malignancy,
the six different LCs. In contrast, HSA had no effect on cytokine affecting approximately 14,000 new individuals per year
production even at very high concentrations. Removal of LC-
in the United States, and remains incurable despite allcontaining media resulted in cessation of IL-6 release. LC-induced
available therapies [10]. Renal failure is a common ac-cytokine release was associated with nuclear translocation of
NF-B subunits p50 and p65, as demonstrated by both EMSA companiment of multiple myeloma and is identified in
and immunocytochemistry. Inhibitors of NF-B, aspirin and up to 50% of patients at presentation. This complication
pyrrolidineditiocarbamate (PDTC) markedly suppressed LC- carries a worse prognosis and low response rate to che-induced cytokine production.
motherapy [11, 12]. Excessive production of light chainsConclusion. LC endocytosis leads to production of inflam-
(LCs) in multiple myeloma and the associated LC pro-matory cytokines through activation of NF-B. This may be
an important mechanism of chronic tubulointerstitial inflam- teinuria often cause various renal disorders. These disor-
mation process commonly seen in multiple myeloma. These find- ders include Fanconi’s syndrome, reflecting PTC toxicity
ings also point out a potential role by filterable low-molecular- [13, 14], concentration and acidification defects, indica-weight proteins, like LCs, in PTC injury during all proteinuric
tive of distal tubule cell toxicity [15] and cast nephropathydiseases.
associated with binding of LCs to Tamm-Horsfall pro-
teins in the distal tubule lumen [16, 17]. The most com-
mon histologic lesion is cast nephropathy, often termed
“myeloma kidney” [18]. LC cast formation in distal tu-
bules in association with Tamm-Horsfall proteins leads
to chronic renal disease, but the precise mechanisms ofKey words: interleukin-6, monocyte chemoattractant protein-1, pro-
teinuria, progressive kidney disease, human serum albumin, myeloma. chronic tubulointerstitial injury and the role of PTCs in
this process have not been fully elucidated.Received for publication April 15, 2002
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result in eventual degradation within the lysosomes additive or potentiating effect on LC-induced cytokine
production.[19, 20]. Therefore, excessive endocytosis of LC is likely
Light chains were collected from patients with minimalto strain the endocytic-catabolic apparatus, possibly re-
or no albuminuria. Thus, the LCs studied here representsulting in release of endosomal/lysosomal contents into
tubulopathic LCs with no clinical evidence of glomerularcytosol and triggering an inflammatory response, as has
involvement. The serum creatinine concentrations ofbeen observed with albumin exposed cells.
these patients ranged from 1.6 to 3.3 mg/dL. Many patientsIn the present study, we evaluated whether cell-traffic
showed an improvement in renal function after they wereoverloading by LCs might induce inflammatory cytokines
started on chemotherapy and supportive treatment. Kid-implicated in progression of kidney disease, such as inter-
ney biopsies were not performed in any of the patients.leukin (IL)-1, IL-6, IL-8, monocyte chemoattractant pro-
Because the LCs were collected over five years fromtein-1 (MCP-1), regulated-on-activation-normal T-cell-
patients in several different hospitals affiliated with ourexpressed-and secreted (RANTES), tumor necrosis factor
program, a detailed follow-up of the eventual clinical(TNF)- and transforming growth factor-1 (TGF-1).
outcomes was not possible.We characterized the cytokine responses in cultured PTCs
The effects of six species of LCs, four  and two to six different LCs isolated from the urine of myeloma
chains, were evaluated on cytokine secretion. These sixpatients with predominantly tubulointerstitial disease.
LCs were the same LCs studied in our previous report
[21]. Two LCs (LC-1, a -LC and LC-2, a -LC) that
METHODS demonstrated significant effects on IL-6 secretion were
selected for additional studies.Isolation and purification of myeloma LCs
Light chains were isolated and purified from the urine Cell cultures
of multiple myeloma patients by slight modification of
Initially the effects of LCs on cytokine production inthe method previously reported from our laboratory [21].
primary cultures of human PTCs (Clontech, Palo Alto,LCs were precipitated from urine with ammonium sul-
CA, USA) were evaluated. After confirming that cyto-fate (55 to 90% saturation-determined empirically), ex-
kine repertoire was identical in both the primary culturestensively dialyzed against distilled water and lyophilized.
and SV40 immortalized human kidney PTCs, all experi-The precipitated LCs were purified by dissolving the
ments were conducted using SV40 PTCs and only data
lyophilized desalted crude protein in buffer at pH 6.0,
obtained in this cell line are presented here. Grown as
followed by chromatography on carboxymethyl-Sepha-
a monolayer, these cells showed marker brush-border
dex (C-50; Pharmacia, Piscataway, NJ, USA). Under these enzymes and had biochemical and morphological charac-
conditions, the LCs were bound to the column, whereas teristics similar to other widely used PTC lines, including
the contaminants were not. Bound LC was eluted with LLC-PK1, OK, HK-2, and human PTCs in stable culture
0.6 mol/L of NaCl, redialyzed against distilled water, and [24]. Brush border enzymes and phloridzin-inhibitable
lyophilized. The purity of LCs was confirmed by sodium glucose transport were similar to other established PTC
dodecyl sulfate (SDS) gel electrophoresis [22] and the models. This transformed cell line’s response to inflam-
immunologic identity reported from the clinical labora- matory stimuli was extensively compared with parental
tory was confirmed by Western blotting using goat anti- PTCs and was found to be similar [25]. Cells were rou-
human  and  antibodies. tinely grown in DRM-23E [24] medium supplemented
These LC preparations were tested for endotoxin using with 0.5% (vol:vol) fetal bovine serum in T-75 flasks
the chromogenic Limulus amebocyte lysate (LAL) test (Falcon, Becton Dickinson Labware, NJ, USA), in the
(Charles River Labs, Charleston, SC, USA). Endotoxin presence of 5% CO2 at 37C.
has previously been shown to induce MCP-1 gene ex-
pression through activation of nuclear factor-B (NF-B) Tracking LC endocytosis by indirect immunofluorescence
in rat tubular epithelial cells at 1 to 10 g/mL concentra- Endocytosis of LC was tested by indirect immunoflu-
tions [23] corresponding to approximately 3000 to 30,000 orescence [26] using fluorescein-isothiocyanate conju-
EU according to the manufacturer’s specifications. We gated (FITC) secondary antibodies against anti-LC anti-
found that all six LCs used in these experiments were bodies. For this purpose, cells were grown on glass cover
essentially endotoxin free (0.1 to 3.7 EU/mg LC protein). slips and then permitted to undergo endocytosis of unla-
The two human serum albumin (HSA) preparations, beled LC. Control slides were exposed to LC-1 at 0C
which were used as negative controls, had 3.1 and 8.5 to stop endocytosis. Cells were allowed to endocytose
EU/mg endotoxin. In additional experiments, no effect LC-1 (200 mol/L) in the medium and then cells were
of endotoxin was found up to 7500 EU/mL on induction fixed in 2% para-formaldehyde (vol:vol) in phosphate-
of IL-6 in our cell preparations, nor did the addition of buffered saline (PBS) made up of 20 mmol/L sodium
phosphate, 150 mmol/L NaCl, and 2 mmol/L MgCl2 atendotoxin to LC in these concentration ranges have any
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pH 7.4. After the cells were washed with PBS, they were amounts of recombinant human cytokines. Experiments
were conducted in triplicate using 96-well micro platespermeabilized with 2 mL of 0.01% (vol:vol) Triton X-100
in PBS buffer for five minutes at 10C and stained with and the results were read in a micro plate reader. Cells
were trypsinized and counted to express the amount ofanti-human LC antibody followed by FITC conjugated
secondary antibody. Endocytosis experiments were done cytokine as ng per 106 cells.
using an immunofluorescence microscope and a digitized
Maneuvers that interfere with LC endocytosisphotomicrography system (Version 3.6; Metamorph
Universal Imaging, West Chester, PA, USA). For this purpose, two different strategies were used.
The first maneuver was pretreatment and treatment with
Evaluation of the effects of LCs and increasing bafilomycin A, which alkalinizes endocytic vesicles by spe-
concentrations of HSA on cytokine production in PTC cifically inhibiting vesicular H-adenosinetriphosphatase
[19]. After a one hour pretreatment with bafilomycin A (1When SV40 PTCs formed a confluent monolayer in
T-75 flask, they were trypsinized and transferred to 24- mol/L) at 37C, cells were exposed to LC-1 (50mol/L)
bafilomycin A (1 mol/L) for six hours, then superna-well tissue culture plates (Costar, Corning Incorporated,
NY, USA). After reaching confluency in 24-well plates, tants were harvested and stored at –70C for cytokine
assays. Second, LC-1 exposure was repeated in mediumcells were first exposed to 400 mol/L concentrations of
six LCs (LC-1 to LC-6) and HSA for 24 hours. At the made hypertonic with 0.25 mol/L sucrose (ICN, Costa
Mesa, CA, USA). Hypertonic medium is known to inter-end of exposure period, supernatants were harvested
and stored at 70C for cytokine assays. Results from fere with clathrin lattice formation and is used as a ma-
neuver to disrupt the clathrin-coated endocytic pathwayinitial screening experiments were used in planning de-
tailed studies. The initial experiments showed significant but not fluid-phase endocytosis [19]. Cells were incu-
bated in hypertonic medium for one hour at 37C. Afterincreases in IL-6, IL-8 and MCP-1, but no significant
changes in IL-1, TGF-1, RANTES and TNF-. Because pretreatment with hypertonic sucrose (0.25 mol/L), con-
fluent monolayers of cells were exposed to 50 mol/Lof the unique associations between myeloma and IL-6,
we focused on this cytokine. For these studies LC-1 () of LC-1 for six hours in the continued presence of 0.25
mol/L sucrose. At the end of the exposure, supernatantsand LC-2 () were selected as they had the most potent
stimulatory effects on cytokine production. were harvested and stored for ELISA at 70C.
Detailed time-course and dose-response studies for
Determination of NF-B activationIL-6 production were conducted using LC-1. Confluent
cell monolayers in 24-well plates were exposed to varying To determine whether LC-induced cytokine produc-
tion is through activation of the NF-B, nuclear translo-concentrations (0, 25, 50, 100, 200, 400 mol/L) of LC-1
for varying time intervals (2, 6, 20, 48 hours). To verify cation of NF-B was evaluated by both immunocyto-
chemistry and EMSA [3, 27].the LC effect, after incubation with LC-1, LC containing
medium was removed and replaced with LC free me- Immunocytochemistry. Cytoplasmic and nuclear lo-
calization of NF-B p65 and p50 subunits were deter-dium, and IL-6 levels were tested in supernatants at one,
two and four hours. Supernatants were harvested and mined by immunofluorescence according to methods de-
scribed previously [28], modified slightly according tostored at 70C at each step for cytokine assays.
Light chain-1 and HSA were dissolved in regular cell the protocol provided by Santa Cruz Biotechnology, Inc.
(Santa Cruz, CA, USA), the source for the antibodies.culture medium. Confluent monolayers of cells were ex-
posed to LC-1 (50 and 100 mol/L) and HSA (50, 100 SV40 cells were grown on sterile glass cover slips, then
placed in 24-well tissue culture plates for overnight atmol/L) for 6 and 24 hours in 24-well plates. Superna-
tants were harvested from each well for cytokine assays. 37C and exposed to LC-1, HSA, 100 mol/L each, and
standard media for one hour. At the end of exposure,HSA was tested at high concentrations (10 and 30 mg/mL,
approximately 160 and 500 mol/L) to compare cytokine cells were fixed using methanol for five minutes at10C
and incubated with 10% normal goat serum for 30 min-responses with LCs.
Interleukin-6, IL-8, MCP-1, RANTES, TGF-1, TNF- utes to eliminate non-specific binding of IgG, and then
washed with PBS. Anti-NF-B p65 and p50 were addedand IL-1 were measured in the supernatants using com-
mercial human ELISA kits (Quantikine; R&D Systems, (1:100) at room temperature for 60 minutes. After wash-
ing with PBS, cells were incubated with secondary fluo-Minneapolis, MN, USA) according to the manufacturer’s
protocol. The sensitivity of the ELISA is less than 0.7 rescein-conjugated antibody (1:100) for 45 minutes and
then were mounted by 90% glycerol. Immunofluorescentpg/mL, 10 pg/mL, 5 pg/mL, 8 pg/mL, 7 pg/mL, 4.4 pg/mL
and 1 pg/mL for IL-6, IL-8, MCP-1 and RANTES, TGF-1, microscope and a digitized photomicrography system
(Metamorph Universal Imaging, Version 3.6) were usedTNF- and IL-1 assays, respectively. Cytokine concen-
trations in the unknown samples were determined by to evaluate the cells.
Electrophoretic mobility shift assay (EMSA). Nuclearinterpolation into a standard curve developed with known
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extracts from cells were prepared as described by Zoja Effects of NF-B inhibitors aspirin and PDTC on
cytokine productionet al [3]. Confluent monolayers of cells were incubated
with 100 mol/L LC-1, LC-2 and HSA for six hours. To confirm the role of NF-B, the effects of NF-B
After washing with PBS, cells were harvested and resus- inhibitors aspirin (20 mmol/L) [30] and pyrrolidineditio-
pended in 2 mL hypotonic buffer [10 mmol/L Hepes, carbamate (PDTC; 12.5mol/L) [31] for one hour prior to
pH 7.6, 15 mmol/L KCl, 2 mmol/L MgCl2, 0.1 mmol/L and during six hours of incubation with LC-1 (50 mol/L)
ethylenediaminetetraacetic acid (EDTA), 1.0 mmol/L were studied on cytokine production. At the end of the
dithiothreitol (DTT), and 0.2% Nonidet P-40]. The sus- incubation, supernatants were harvested and stored for
pension was centrifuged at 650 	 g after incubating for cytokine assays. Aspirin and PDTC were dissolved in reg-
five minutes on ice and the pellet was then washed once ular media and freshly prepared each time before the
experiments. The concentration of aspirin (20 mmol/L)with the same buffer. The resulting nuclear pellet was resus-
and PDTC (12.5 mol/L) used were determined frompended in 300 L buffer [25 mmol/L Hepes, 50 mmol/L
pilot studies.KCl, 0.1 mmol/L EDTA, pH 8.0, 1.0 mM DTT, 10%
All antibodies and chemicals were purchased from(vol:vol) glycerol] and 0.4 mol/L NaCl. This suspension
Sigma Chemical Co. (St. Louis, MO, USA) unless other-was incubated for 45 to 60 minutes at 4C and centrifuged
wise specified.at 18,000 	 g for 10 minutes. The supernatant, which is
the nuclear extract, was divided into aliquots and stored
Statistical analysisat 70C until use.
Results were expressed as mean
 SEM. Multiple com-The oligonucleotide used as a probe for EMSA was a
parisons were made by analysis of variance (ANOVA)42-bp double-stranded construct (wild-type) 5-TTGT
and Bonferroni’s multiple-comparison tests. StatisticalTACAAGGGGACTTTCCGCTGGGGACTTTCCAG
analyses, curve fitting, and calculations were done usingGGAGGC-3 containing two tandemly repeated NF-B
GraphPad Prism, version 3 for Windows NT (1999, Graph-binding sites (underlined) were obtained from Dr. Vancu-
Pad Software Inc, San Diego, CA, USA). Statistical sig-rova (New Hyde Park, NY, USA). Mutant oligonucleotide
nificance was defined as P  0.05.used for competition studies was 5-TTGTTACAATCT
CACTTTCCGCTTCTCACTTTCCAGGGAGGC-3.
End labeling was accomplished by treatment with T4 ki- RESULTS
nase in the presence of 32P ATP, and the labeled oligo- LC endocytosis by indirect immunofluorescence
nucleotide was purified on a Sephadex G-25 column, as
Light chain endocytosis was confirmed during thesedescribed [29]. Briefly, nuclear protein extracts (5 g pro-
experiments by immunocytochemistry before proceed-
tein, 106 cell equivalent, in 5 to 7 L) prepared from PTCs
ing with cytokine assays. After a four hour exposure
were incubated (20 min at room temperature) with 5 to
there was brisk endocytosis of LC by PTCs with vacuolar
10 fmol of radiolabeled oligonucleotide (70,000 cpm) localization in the cytoplasm (Fig. 1). We had demon-
in 20 L of binding buffer (20 mmol/L Tris-Cl, pH 7.5, strated previously that LCs undergo receptor-mediated
150 mmol/L KCl, 1 mmol/L EDTA, 1 mmol/L DTT, 0.1% endocytosis by radioisotope and flow cytometry via bind-
NP-40, 6% glycerol) supplemented with 20 g acetylated ing to cubilin in cultured PTCs [19, 20]. Our work also
BSA and 2 g poly (dI-dC). For competition experi- showed that LC endocytosis occurs through the clathrin-
ments, binding reactions were performed in the presence coated pathway and results in significant degradation.
of 30 molar excess of unlabeled (wild-type) oligonucleo-
tide before adding the 32P labeled probe. For supershift Effects of tubulopathic LCs on IL-6 production
experiments, 1 g of specific polyclonal antibody against Focusing our studies on IL-6 responses in view of its
p50, p65 and c-rel were added and incubated 30 minutes unique association with multiple myeloma, the effects
at room temperature before introducing the 32P-labeled of six different LCs on the production of IL-6 in SV40
oligonucleotide. The resulting complexes were resolved PTCs were evaluated. All LCs stimulated production of
on 5% non-denaturing polyacrylamide gels that had been IL-6 (3- to 15-fold, compared to control) while HSA had
pre-run at 100 V for 30 minutes in 0.5 	 TBE buffer. no significant effect (Fig. 2). There was considerable
Electrophoresis was conducted at 180 V for 2.5 hours. variability among the LCs tested here. Two LCs [LC-1
After electrophoresis, gels were transferred to Whatman () and LC-2 ()] had the most marked effect on produc-
DE-81 paper, dried and exposed to autoradiographic tion of IL-6. The IL-6 response to LC-1 was time- and
film (Kodak Biomax MS; Eastman Kodak, Rochester, dose-dependent (Fig. 3). The maximum effect of LC-1
NY, USA) with an intensifier screen at 80C. Each gel was seen within six hours of exposure and persisted for
was exposed to the film for different lengths of time to more than 48 hours, the longest time interval tested in
these studies (Fig. 3A). The half-maximal effect wasgenerate series of images with different intensities.
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Fig. 1. Tracking light chain-1 (LC-1) endocytosis by immunocytochem-
istry in proximal tubule cells. LC-1 is localized in the cytosol of two
adjacent cells in vacuolar distribution (	100, oil immersion; details are
in the Methods section).
Fig. 3. Time-course and dose-response of IL-6 induction by LC-1. (A )
Time-course study showed that the maximal effect of LC-1, 400 mol/L,
on IL-6 production was seen at six hours and this effect was sustained
over 48 hours; longer time intervals were not studied. (B) Dose-response
experiment showed that half-maximal stimulatory dose of LC-1 was20
mol/L at the end of a 24-hour exposure. Each point represents the
mean of triplicate measurements.
of a patient with multiple myeloma. Free LC concentra-
tion in the serum of myeloma patients can be more than
1000-fold of normals; for example, free -LCs ranged
from 4.2 to 3514 mg/L and free -LCs from 1.1 to 7770
mg/L in a report by Solling et al [32], yielding theoretical
proximal tubule fluid concentrations up to approximately
300 mol/L, and exceeding these levels as tubular fluid
Fig. 2. Effects of six different light chains (LCs) and human serum is reabsorbed along the proximal tubule. Furthermore,
albumin (HSA) on interleukin-6 (IL-6) production. All LCs stimulated free LC excretion in the urine of myeloma patients can
the production of IL-6 in 24 hours (***P  0.001 vs. control, **P 
be as high as 32 g/day [33].0.001 vs. HSA), while HSA had no effect (*P 0.05 vs. control). Results
are presented as mean 
 SEM. To confirm the role of LC in the induction of IL-6,
LC containing medium was removed and the same cells
incubated with LC free medium; the continued presence
of LC was required for a continued release of IL-6 into
observed at approximately 20 mol/L concentration of medium (Fig. 4). We also looked for IL-6 in LC con-
LC-1 (Fig. 3B). These concentrations are well within the taining medium before all experiments and did not detect
measurable quantities of IL-6, indicating that IL-6 con-range that can be achieved in the proximal tubule fluid
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Fig. 4. IL-6 production requires the continuous presence of LC-1. Cells
were incubated in medium without () or with ( ) LC-1 for 24 hours.
Upon replacement with fresh medium (time 0) containing no LC-1, IL-6
production promptly ceased and by 1 hour was not different from time-
matched controls.
tamination does not occur during purification of LC from
the urine of the patients.
Effects of LC-1 and HSA on IL-6, IL-8 and
MCP-1 production
Light chain-1 (1.5 and 3 mg/mL;50 and 100 mol/L)
stimulated production of IL-6 at six and 24 hours of
exposure, while HSA had no effect even at high concen-
trations (10 and 30 mg/mL, 160 and 500 mol/L) at
the same exposure intervals (Fig. 5).
The effects of increasing concentrations of HSA and
LC-1 (50, 100 mol/L) on IL-8 and MCP-1 production
by PTCs are shown in Figures 6 and 7. After 6 and 24 hours
of exposure to LC-1 there were increased productions of
Fig. 5. Effects of LC-1 and HSA on IL-6 production at 6 (A ) andIL-8 (Fig. 6) and MCP-1 (Fig. 7). In contrast, exposure to
24 hours (B ). Cells were incubated with control medium or mediumHSA, even at a 30 mg/mL concentration (500 mol/L containing LC-1 (50 and 100 mol/L) and HSA (50 to 500 mol/L) for
concentration) had no effect on IL-8 and MCP-1 produc- 6 (A) and 24 (B) hours. LC-1 both at 50 and 100 mol/L significantly
stimulated IL-6 production at 6 and 24 hour exposures, while HSA hadtion. None of the LCs studied here had stimulatory ef-
no effect at any concentrations studied. Results are presented as mean
fects on the production of TGF-1, IL-1, TNF- or SEM (***P  0.001 vs. control, *P  0.05 vs. control).
RANTES (data not shown).
Effects of maneuvers that interfere with LC experiments, bafilomycin A and sucrose on cytokine pro-
endocytosis on IL-6, IL-8 and MCP-1 production duction without the presence of LC-1 had no effects by
Two different maneuvers that interfere with LC endo- themselves on cytokine production in PTCs.
cytosis resulted in inhibition of the cytokine response
NF-B translocation by immunocytochemistryinduced by LC-1 (Fig. 8). First, alkalinization of endoso-
and EMSAmal contents by bafilomycin A (1 mol/L), which results
in disruption of endosomal fusion and presumably dis- Activation of NF-B in PTCs exposed to LC-1, LC-2
rupts LC traffic in the cytosol [19], resulted in significant and HSA was probed by both immunocytochemistry
inhibition of the IL-6, IL-8 and MCP-1 (Fig. 8A). Simi- (Fig. 9) and EMSA (Fig. 10A). By immunocytochemis-
larly, rendering the medium hypertonic by 0.25 mol/L try, the p65 subunit of NF-B was seen in a cytoplasmic
sucrose [19], an intervention known to disrupt clathrin- distribution in control cells (Fig. 9A). In cells exposed
coated pathway, reduced the cytokine response to LC-1 to LC-1 and LC-2, p65 was localized primarily to the
by more than 75% (Fig. 8B), attesting to the mechanistic nuclei (Fig. 9 B, C). In contrast, there was no discernible
nuclear translocation of p65 in HSA-exposed cells (Fig.role of LC endocytosis in these responses. In the same
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Fig. 6. Effects of LC-1 and HSA on IL-8 production at 6 (A ) and 24
hours (B). Cells were incubated with different concentrations of LC-1
Fig. 7. Effects of LC-1 and HSA on MCP-1 production at 6 (A ) andand HSA for 6 (A) and 24 (B) hours. Production of IL-8 was stimulated
24 hours (B ). Cells were incubated with different amounts of LC-1by LC-1 while HSA had no significant effect even at high concentrations.
and HSA for 6 (A) and 24 (B) hours. LC-1 significantly stimulatedResults are presented as mean 
 SEM (***P  0.001 vs. control, *P 
production of MCP-1 while HSA had no effect. Results are presented0.05 vs. control).
as mean 
 SEM (***P  0.001 vs. control, *P  0.05 vs. control).
9D). Similar responses were observed for p50 distribu-
otide did not affect either band (Fig. 10B, lane 3). Totion (data not shown).
analyze the subunit composition of these two complexes,Electrophoretic mobility shift assay (EMSA) experi-
a supershift assay was performed using polyclonal anti-ments with two different LCs (LC-1, a  and LC-2, a )
bodies against p50, p65 and c-Rel subunits of NF-Bconfirmed nuclear translocation of both the p50 and p65
(Fig. 10B, lanes 4, 5 and 6, respectively). The supershiftsubunits of NF-B in nuclear extracts (5 and 9.5 g)
experiment confirmed the presence of both p50 and p65obtained from LC exposed cells (Fig. 10A). Again, there
subunits in the nuclear extracts obtained from LC ex-appeared to be no distinct response to HSA exposure. To
posed cells (Fig. 10B).confirm the specificity of the DNA-protein interaction,
competition studies were performed with unlabeled oli-
Effects of NF-B inhibitors on LC-inducedgonucleotides (Fig. 10B). Addition of the 30-fold excess
cytokine responsesof unlabeled wild-type 42-bp NF-B oligonucleotide re-
Introduction of inhibitors of NF-B, aspirin and PDTC,sulted in the complete disappearance of both complexes
(Fig. 10B, lane 2), whereas unlabeled mutant oligonucle- into the medium nearly eliminated the LC-induced cyto-
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PTCs may be an important mechanism of the chronic
tubulointerstitial inflammation frequently seen in multi-
ple myeloma. Chronic tubulointerstitial nephritis in con-
junction with distal tubular casts, formed by binding of
LCs to Tamm-Horsfall glycoproteins is the “classical”
myeloma kidney [18]. Meticulous investigations by Sand-
ers et al have clarified the pathophysiology of cast forma-
tion and have characterized specific binding sequences in
Tamm-Horsfall protein with high affinity to “castogenic”
LCs [16, 17]. Although these studies offered much insight
into the pathogenesis of myeloma kidney, they could not
fully link the extensive tubulointerstitial inflammatory
cellular infiltration, tubular atrophy and fibrosis to the
distal tubule luminal casts. The results of the experiments
here reveal a potential role for the most abundant cells
in the kidney, the proximal tubular epithelial cells, in
the pathogenesis of chronic tubulointerstitial inflamma-
tion in patients with LC proteinuria.
Previous studies from our laboratory have demon-
strated that myeloma LCs bind to endocytic receptors
located in the PTC apical membrane [19, 20, 34]. The
recently cloned cubilin is one of these endocytic scaven-
ger receptors, similar to megalin. Radioisotope labeled
LC binding and internalization studies and direct binding
assays by surface plasmon resonance analysis demon-
strated LC interaction with cubilin [20]. That LC binding
to apical membranes is followed by internalization and
routing to the endosomal-lysosomal degradative pathway
was confirmed by antibody inhibition and flow cytometry
studies. The present study tracked LC endocytosis by
immunocytochemistry and found brisk endocytosis and
a vacuolar distribution of LCs in the cytosol of the cellsFig. 8. Effects of bafilomycin A (Baf) and hypertonic sucrose (Suc)
on IL-6, IL-8 and MCP-1 production. Bafilomycin A (A ) and hypertonic (Fig. 1). This observation suggests that endocytosis and
sucrose (B ) inhibited LC-1 induced IL-6 (), IL-8 ( ), and MCP-1 cytokine responses may be causally related. The maneu-() production. Bafilomycin A alone or sucrose alone had no effect.
vers that we had previously demonstrated to inhibit LCResults are presented as mean 
 SEM (***P  0.001 vs. LC-1, **P 
0.05 vs. LC-1, *P  0.05 vs. control). endocytosis in PTCs, hypertonicity and bafilomycin A
[19], resulted in significant inhibition of cytokine responses
(Fig. 8), strengthening the argument that endocytosis is
required for cytokine responses. However, the effects ofkine response (Fig. 11), supporting that LC-exposed cy-
these maneuvers were less than complete, suggestingtokine induction is mediated through the activation of
that mechanisms other than endocytosis, for example,this transcription factor. In simultaneous experiments,
surface binding, also may contribute to these responses.we also tested the effects of the same concentrations of
Similar explanations have been proposed by other in-aspirin and PDTC on cytokines production without the
vestigators who observed that albumin induces cellularpresence of LC-1 and found no effect.
stress responses including cytokine release in various
PTC cultures, such as, opossum kidney (OK) cells, the
DISCUSSION porcine cell line LLC-PK1, and human PTCs [3, 6, 7,
35]. These investigators have generally attributed theThese studies show that endocytosis of LCs by PTCs
can result in induction of pro-inflammatory and inflam- cytokine responses to “protein overloading” as a result
of excessive albumin endocytosis by these cells and havematory cytokines. Although our studies focused mostly
on IL-6 production, a cytokine uniquely involved with proposed protein overloading as a principal mechanism
of progression in chronic renal insufficiency. Althoughmultiple myeloma, they also provide clear evidence of
the production of MCP-1 and IL-8 in human PTCs ex- our observations are in general agreement with this con-
cept, there are some significant differences between ourposed to myeloma LCs. The obvious implication of these
observations is that LC-induced cytokine secretion by findings using LCs and reports in the literature on albu-
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Fig. 9. Localization of NF-B in PTCs by
immunofluorescence microscopy. Cytoplasmic
localization of NF-B (p65 subunit) is seen
in unstimulated cells (A ). After one hour of
exposure to LC-1 (B ) and LC-2 (C ), fluores-
cence appears predominantly in the nuclei of
the PTCs. In cells exposed to HSA, the immu-
nofluorescence is located predominantly in
the cytoplasm (D ).
min-exposed cells. Most of the experiments have used of transcription factors triggering nuclear transcription
of inflammatory and pro-inflammatory cytokines. Thebovine serum albumin (BSA) with cells derived from
other species, such as pig or opossum. In contrast, our families of nuclear transcription factors, such as NF-B,
that regulate numerous cell injury/inflammation reactionsexperiments used only human kidney cells and our LCs
were isolated from humans. Crossing species may have have attracted considerable attention in studies addressing
the role of protein overloading in chronic renal diseasealtered immune responses in these in vitro systems. In
further and starker contrast, we found that HSA evoked [3, 6–8, 31, 38]. These transcription factors participate
in various injury responses including interactions witheither no or at best minimal cytokine responses, even at
very high concentrations, in our human PTCs (Figs. 2, chaperone proteins, heat shock proteins, cytokines, apo-
ptotic pathways and oxidative stress [39]. The NF-B5 to 7). The quantitative responses seen in our experi-
ments are difficult to compare with those observed with family includes the subunits p50, p52, p65, etc., and an
inhibitory IB subunit [39–41]. These components arealbumin and LLC-PK1 cells, although when normalized
to cell numbers, our responses appear several orders of constitutively present in the cytoplasm and form dimeric
complexes. All known inflammatory stimuli, includingmagnitude greater. LCs have a much higher affinity to
endocytic receptors than albumin, as we have previously many viruses, involve interactions with cell surface re-
ceptors initiating a phosphatase cascade that ends withreported in competition experiments [19, 34, 36], and
are more likely to be endocytosed in significant quanti- a kinase (known as IB kinase or IKK), which phosphor-
ylates IB [39]. This permits serial insertion of a chainties than albumin. It is conceivable that in experiments
where comparison with a more potent protein, such as of ubiquitin proteins on IB, which induces the release
of IB, freeing the NF-B subunits to be translocatedLCs, is absent, albumin-evoked cytokine responses may
appear significant even if at lesser magnitudes. A relative to the nucleus and bind to defined promoter sequences
on multiple inflammatory genes, releasing diverse reper-lack of effect by albumin was recently reported by Bazzi
et al, demonstrating that in membranous nephropathy toire of inflammatory mediators [40, 41]. Our results
show that LC endocytosis triggers nuclear translocationthe prognosis of kidney disease correlated more signifi-
cantly with the quantity of immunoglobulin in the urine of NF-B (Figs. 9 and 10), suggesting that the cytokine
responses occur through activation of these transcriptionthan albumin [37]. Nevertheless, many investigators have
observed some albumin endocytosis in PTCs [3, 7, 31, factors. Although NF-B activation has been attributed
to “protein overloading” of cytosolic traffic, the precise35] and the differences observed here cannot absolve
albumin as a potential participant in protein overloading mechanisms and the patterns of signaling pathways, such
as mitogen-activated protein kinases, involved in thishypothesis.
A significant component of the protein-overloading response remain to be characterized.
That the NF-B inhibitors aspirin and PDTC amelio-hypothesis is that excessive endocytosis causes activation
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Fig. 11. Effects of aspirin (ASA) and pyrrolidineditiocarbamateFig. 10. EMSA and supershift assay for NF-B. (A ) EMSA for detec- (PDTC) on LC-1 stimulated IL6, IL-8 and MCP-1 production. Produc-tion of NF-B subunits was performed using 5 g (lanes 1-4) and 9.5 tion of IL-6 (), IL-8 ( ) and MCP-1 () were inhibited by aspirin
g (lanes 5-8) nuclear extracts. Results show increased NF-B (p65 (20 mmol/L; A ), and PDTC (12.5 mol/L; B ), both inhibitors of NF-B.and p50 subunits) binding in nuclear extracts of the LC-1 (lanes 2, 6) Neither ASA alone nor PDTC alone had significant effects on cytokineand LC-2 (lanes 3, 7) treated cells compared with nuclear extracts of production. Results are presented as mean 
 SEM (***P  0.001 vs.the control (lanes 1, 5) and HSA (lanes 4, 8) treated cells. (B ) Supershift LC-1, **P  0.05 vs. LC-1, *P  0.05 vs. control).assay. Nuclear extracts from cells treated with LC-2 were incubated
with NF-B specific DNA probe alone (lane 1) or in presence of 30-fold
molar excess of a specific competitor (wild-type, 42-bp) oligonucleotide
(lane 2) or a nonspecific competitor (mutant) oligonucleotide (lane 3).
Antibodies for the supershift assays: p50 (lane 4), p65 (lane 5), and had no effect, glomerulopathic LCs were either internal-
c-Rel (lane 6). This experiment is representative of two and shows
ized or bound to the surface of mesangial cells and causedparticipation of p65 and p50 subunits.
dramatic cytomorphological alterations or elicited in-
flammatory response including production of MCP-1 and
PDGF- through activation of NF-B. These studies
rate cytokine responses (Fig. 11) confirm the role of shed significant insight into mechanisms of LCDD and
NF-B in LC-induced cytokine response. This observa- LC amyloidosis, and show that different LCs utilize simi-
tion lends further credence to the protein-overloading lar pathogenic pathways in different cell populations.
hypothesis and identifies a step in the pathogenesis of Our LCs were isolated from patients with minimal or no
myeloma nephropathy potentially amenable to thera- albuminuria and no clinical evidence for any glomerular
peutic interventions. disease. These observations show that different LCs may
Strikingly similar effects of LCs isolated from patients utilize similar inflammatory pathways on different cell
with amyloidosis and LC deposition disease (LCDD) on types resulting in different consequences.
mesangial cells were described by Russel et al [42]. These The cytokine responses observed here suggest a prom-
inent role for IL-6. IL-6 was originally identified as ainvestigators observed that although tubulopathic LCs
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26 kD protein in supernatants from antigen- or mitogen- in albuminuric states. Immunoglobulin LCs are the most
abundant proteins among this group of proteins thatstimulated mononuclear cells, which induced immuno-
globulin synthesis by activated B cells [43–45]. Later, IL-6 are likely to mediate such cytokine responses leading to
chronic tubulointerstitial inflammation either as a pri-production in many other cell types including glomerular
mesangial and PTCs was reported in response to lipo- mary event or as a process responsible for progression
polysaccharide, IL-1 and TNF- [46–48]. IL-6 has pleio- of kidney disease in proteinuric states.
tropic proinflammatory effects in many cell types. It is
the principal mediator of acute phase response and has ACKNOWLEDGMENTS
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